Aspartate Aminotransferases

• 

  Subject Areas on Research

  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • A CORRELATION BETWEEN THE PROTEIN STRUCTURE AND CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE. 
  • A kinetic investigation of the interaction of alpha-methylaspartic acid with aspartate aminotransferase. 
  • A kinetic investigation of the interaction of erythro-beta-hydroxyaspartic acid with aspartate aminotransferase. 
  • A prospective case-control study to investigate retinal microvascular changes in acute dengue infection. 
  • A temperature jump study of aspartate aminotransferase. a reinvestigation. 
  • AN OPTICAL ROTATORY DISPERSION STUDY OF ASPARTIC AMINO TRANSFERASE. 
  • AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study. 
  • Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. 
  • Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. 
  • Accuracy of total serum enzymes and myocardial specific isoenzymes--a comparative study. 
  • Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine. 
  • Acute pancreatitis and fulminant hepatic failure. 
  • Acute, subacute, and residual effects of polychlorinated biphenyl (pcb) in rats. II. Pathology and electron microscopy of liver and serum enzyme study. 
  • Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. 
  • Analysis of injury in complex organ preservation. 
  • Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation. 
  • Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. 
  • Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. 
  • Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. 
  • Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. 
  • Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. 
  • Bile flow--an index of ischemic injury. 
  • Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. 
  • Capillary electrophoresis with electrochemiluminescence detection for measurement of aspartate aminotransferase and alanine aminotransferase activities in biofluids. 
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. 
  • Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. 
  • Clinical manifestations of congenital syphilitic hepatitis: implications for pathogenesis. 
  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. 
  • Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. 
  • Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. 
  • Concerning the role of metals in enzymic transamination. 
  • Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C. 
  • Cyclosporine increases hepatocyte synthesis of the immunosuppressive free radical nitric oxide. 
  • Cytokine storm of acute necrotizing encephalopathy. 
  • Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. 
  • Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. 
  • Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. 
  • Does this patient with liver disease have cirrhosis? 
  • Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. 
  • Du Pont aca and Dow AST/ALT-UV (PLP activated)-centrifugal analyzer serum aspartate aminotransferase assays compare well. 
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
  • Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. 
  • Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 
  • Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. 
  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). 
  • Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. 
  • Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. 
  • Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. 
  • Gallstone formation during weight-reduction dieting. 
  • Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. 
  • Glycogenic Hepatopathy Causing Elevated Lactic Acid and Liver Enzymes. 
  • Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. 
  • How do enzymes really work? 
  • Hypotensive effects of clonidine and chlorthalidone. Controlled clinical trial of drugs administered singly and in combination. 
  • Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. 
  • Interleukin 1-induced production of nitric oxide inhibits benzenetriol-mediated oxidative injury in rat hepatocytes. 
  • Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. 
  • Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. 
  • Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? 
  • LDH isoenzymes and myocardial infarction in patients undergoing coronary bypass surgery: an excellent correlation. 
  • Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. 
  • Late appearance of skin rash and abnormal serum enzymes in Rocky Mountain spotted fever. A case report. 
  • Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. 
  • Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. 
  • Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function. 
  • Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. 
  • Major hepatic trauma: warm ischemic tolerance of the liver after hemorrhagic shock. 
  • Malfunction of the liver after transplantation: an analysis of potential risk factors. 
  • Marked transaminase elevation in anorexia nervosa. 
  • Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. 
  • Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. 
  • Methylphenidate-induced autoimmune hepatitis. 
  • MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection. 
  • Multiple conformational changes in enzyme catalysis. 
  • Natural history of neonatal herpes simplex virus infections in the acyclovir era. 
  • Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. 
  • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. 
  • Normal serum activities of some diagnostic enzymes in dromedary camel in Sudan. 
  • Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. 
  • Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. 
  • Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. 
  • Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas. 
  • Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index. 
  • Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. 
  • Pretransplant status and patient survival following liver transplantation. 
  • Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. 
  • Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. 
  • Relaxation spectrometry of biological systems. 
  • Serum enzyme alterations after extensive surgical procedures. 
  • Serum enzyme alterations in hypothyroidism before and after treatment. 
  • Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. 
  • Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. 
  • Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. 
  • The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. 
  • The effect of protein nutrition on host and tumor metabolism. 
  • The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. 
  • The effects of hepatic cryosurgery on tumor growth in the liver. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The interaction of aspartate aminotransferase with alpha-methylaspartic acid. 
  • The prevalence and etiology of elevated aminotransferase levels in the United States. 
  • The relationship between hepatitis B surface antigen and antibody and continued drug use in narcotic dependency: a randomized controlled study. 
  • The toxic effects of Tephrosia apollinea on goats. 
  • Thermodynamic parameters of the alpha-methyl aspartate-aspartate aminotransferase interaction. 
  • Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers. 
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? 
  • Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. 
  • ULTRAVIOLET ROTATORY DISPERSION OF ASPARTIC AMINOTRANSFERASE. 
  • Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. 
  • [Idiophatic inflammatory myophaties: its asociation with liver disorders]. 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology